TSPO and hepatocellular carcinoma: TSPO knockdown has been shown to disrupt mitochondrial function in hepatocellular carcinoma (HCC) by increasing ROS production and lowering mitochondrial membrane potential (ΔΨm), which in turn inhibited HCC cell proliferation [44].